Abstract
Because stimulant use disorders remain prevalent across the lifespan, cognition is an important area of clinical care and research focus among aging adults with stimulant use disorders. This secondary analysis of a National Institute on Drug Abuse Clinical Trials Network study suggests that decision making, verbal learning/memory, executive function, and set shifting are important cognitive domains to screen clinically and treat in aging adults with stimulant use disorders. Some suggestions are made on how clinical treatment providers can practically use these results. An important direction for future research is the development of cognitively remediating treatments for impaired cognitive domains in aging adults with stimulant use disorders.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 206-216 |
| Number of pages | 11 |
| Journal | Journal of Addictive Diseases |
| Volume | 32 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2013 |
Bibliographical note
Funding Information:The authors alone are responsible for the content and writing of the manuscript. The National Institute on Drug Abuse (NIDA) contributed to the development of study design and initial protocol. Analysis, interpretation, manuscript preparation, and decision to submit the manuscript for publication was the sole responsibility of the authors. The publications committee of the NIDA Clinical Trials Network approved the final manuscript. The study in this manuscript was funded by the NIDA grant U10DA013732 (PI: Winhusen). Dr. Kalapatapu was funded by NIDA grant K23DA 034883. Dr. Vinogradov is a paid consultant in Brain Plasticity, Inc., a company with a commercial interest in cognitive training software. Dr. Vinogradov is also a consultant to Amgen, Genentech, and Hoffman-LaRoche. The authors are unaware of any other affiliations, funding, or financial holdings that might be perceived as affecting the objectivity of this manuscript.
Keywords
- Addiction
- Aging
- Cocaine
- Methamphetamine
- Neurocognitive
